An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...

A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedicines routinely aggrandize their AI ...

In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI) models in ...

On January 6, 2025, the FDA released draft guidance on using artificial intelligence (AI) in regulatory decision-making for ...

Intelligent Omics' Dr Rob Grundy discusses how combining AI with big data can lead to better drug discovery processes and that partnerships can help more organisations leverage cutting-edge tools.

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

in Japan and elsewhere,” but the U.S. has a key adversarial relationship with China when it comes to AI development. The competition has important implications for both our economy and national ...

Drug discovery has long been plagued by high costs, inefficiencies and high failure rates. Therefore, many companies are now adopting AI to accelerate innovation and improve outcomes across every ...

AI's application in drug discovery claimed a significant 46.7% of the market share in 2023, propelled by its ability to optimize safety and efficacy in drug development. AI technologies are ...